ID   F3II
AC   CVCL_E119
DR   Wikidata; Q54833120
RX   CelloPub=CLPUB00707;
RX   DOI=10.1158/1538-7445.AM2020-2649;
RX   PubMed=8691844;
CC   Doubling time: 17.7 hours (PubMed=8691844); 22.80 hours (CelloPub=CLPUB00707).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4Y25 ! M3
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
RX   CelloPub=CLPUB00707;
RA   Sidabra J.E., Capobianco C.S., Gottardo M.F., Alonso D.F., Farina H.G.;
RT   "Isolation and characterization of murine mammary cell lines with
RT   differentiated aggressive phenotype.";
RL   Medicina 78 Suppl. 3:A412-A412(2018).
//
RX   DOI=10.1158/1538-7445.AM2020-2649;
RA   Sidabra J.E., Capobianco C.S., Gottardo M.F., Alonso D.F., Farina H.G.;
RT   "Isolation and characterization of novel murine mammary cell line with
RT   dormant phenotype and identification of new potential targets by mass
RT   spectrometry.";
RL   Cancer Res. 80 Suppl. 16:2649-2649(2020).
//
RX   PubMed=8691844; DOI=10.1002/(SICI)1096-9098(199608)62:4<288::AID-JSO14>3.0.CO;2-1;
RA   Alonso D.F., Farias E.F., Urtreger A.J., Ladeda V.E.,
RA   del Carmen Vidal M., Bal de Kier Joffe E.D.;
RT   "Characterization of F3II, a sarcomatoid mammary carcinoma cell line
RT   originated from a clonal subpopulation of a mouse adenocarcinoma.";
RL   J. Surg. Oncol. 62:288-297(1996).
//